Study on the clinical significance of Saireito in patients with hypertensive nephropathy
Not Applicable
- Conditions
- hypertensive nephropathy
- Registration Number
- JPRN-UMIN000011825
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
* in pregnancy and lactating * contraindicative or impossible to use for some reason for Saireito * treated with oral corticosteroids or immunosuppressant therapy * interstitial pneumonitis * definite diabetes mellitus * marked renal impairment (eGFR = or < 30 ml/min) * primary renal disease * secondary renal disease * serious CHF * serious arrythmia * within 6 months after AMI * within 6 months after cerebrovascular disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in microalbuminuria
- Secondary Outcome Measures
Name Time Method